Time to first decision with review:
Time from acceptance to publication:
Impact Factor rank (JCR):
Aims and scope
British Journal of Ophthalmology is an international peer-reviewed journal for ophthalmologists and visual science specialists that publishes clinical investigations, clinical observations, and clinically relevant laboratory investigations related to ophthalmology. Main features include articles on both clinical and laboratory sciences, up-to-date major reviews, editorials, education articles and letters. The 'Innovations' section features papers on surgical, diagnostic and therapeutic innovations. British Journal of Ophthalmology is BMJ's flagship ophthalmology journal and has an open access companion journal, BMJ Open Ophthalmology.
For information about the British Journal of Ophthalmology editorial team and the Editor-in-Chief, Frank Larkin, please refer to the Editorial Board page.
Plan S compliance
British Journal of Ophthalmology is owned by BMJ
Subscription; with hybrid open access option
Web of Science Core Collection: Science Citation Index, Science Citation Index Expanded; BIOSIS Previews, Current Contents: Clinical Medicine, Life Sciences; MEDLINE (Index Medicus), PubMed Central (BMJ Open Access Special Collection), Scopus, Embase (Excerpta Medica), CINAHL, Google Scholar
Peer review model
Single anonymised; the names of reviewers are hidden from the author
Acceptance rate: 15%
Speed Time to first decision without review: 3 days (median) Time to first decision with review: 44 days (median) Time from acceptance to publication: 13 days (median)
Impact Impact Factor category: Ophthalmology Impact Factor (JCR): 5.908 Impact Factor rank: 7/61 5 Year Impact Factor: 5.485 Journal Citation Indicator: 1.95 Eigenfactor: 0.02051 Citescore: 8.4 Citescore rank: 6/124 Scimago Journal rank (SJR): 1.8
Reach 2021 total content views: 1,067,530 2021 total Altmetric mentions: 5,410
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure. How we get these metrics
For all contact information please refer to the Contact Us page.
Please refer to the Instructions for Authors.
Rights and permissions
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.